Mexico - Delayed Quote MXN
Carvana Co. (CVNA.MX)
4,670.06
0.00
(0.00%)
At close: April 25 at 12:42:10 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 17 | 17 | 24 | 21 |
| Avg. Estimate | 3.98B | 4.2B | 16.51B | 19.78B |
| Low Estimate | 3.64B | 3.93B | 14.3B | 17.61B |
| High Estimate | 4.25B | 4.47B | 17.53B | 22.15B |
| Year Ago Sales | 3.06B | 3.41B | 13.67B | 16.51B |
| Sales Growth (year/est) | 29.93% | 23.29% | 20.73% | 19.85% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CVNA.MX | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 4/28/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 4/22/2025 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 4/9/2025 |
| Maintains | Citigroup: Buy to Buy | 4/8/2025 |
| Maintains | Baird: Neutral to Neutral | 4/4/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 3/27/2025 |